MedTrace Logo

A Digital Non-interventional Atrial Fibrillation (AF) Screening Study With Commercial Pulse Detection Systems

NCT02875106 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 165

Last updated 2020-05-08

No results posted yet for this study

Summary

The primary objective in this study is to identify commercial pulse detection systems (CPDS) parallel to electrocardiogram (ECG) recording within routine clinical setting, which are able to detect atrial fibrillation or sinus rhythm of screened patients.

Conditions

Interventions

DEVICE

12-point-ECG

routine recording will be 300 seconds

DEVICE

Polar V800

routine recording will be 300 seconds

DEVICE

360° eMotion FAROS SET + Belt

routine recording will be 300 seconds

DEVICE

Adidas Micoach smart run

routine recording will be 300 seconds

DEVICE

TomTom Runner Cardio HRM

routine recording will be 300 seconds

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-08
Primary Completion
2019-04-05
Completion
2019-05-08

Countries

  • Germany

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02875106 on ClinicalTrials.gov